Joe M. O’Sullivan
University College Dublin(IE)Queen's University Belfast(GB)Belfast Health and Social Care Trust(GB)University of Ulster(GB)Queen Mary Hospital(CN)Belfast City Hospital(GB)Institute of Public Health(IE)The Northern Ireland Cancer Centre(GB)The Geneva Foundation(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Diagnosis and Treatment, Advanced Radiotherapy Techniques, Medical Imaging Techniques and Applications
Most-Cited Works
- → Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer(2013)3,300 cited
- → Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial(2015)1,944 cited
- → Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy(2017)1,740 cited
- → Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial(2016)1,289 cited
- → Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial(2018)1,235 cited
- → Gold nanoparticles as novel agents for cancer therapy(2012)1,023 cited